Deepinder Goyal is launching Temple, a brain-blood-flow wearable

Signals Inbox·August 22, 2026·Consumer Health

Deepinder Goyal is moving Temple closer to a consumer launch. The forehead-worn device is designed to track cerebral blood-flow and oxygenation signals, a much more ambitious target than the heart rate, temperature and movement data collected by most rings and watches. The interesting part is that the hardware is arriving before the evidence is fully mature.

Q1What is the official source?

Goyal announced the latest version of Temple in his own launch update. He said the device is now less than half its previous size, that limited-edition pre-orders will open soon and that shipments are planned before the end of 2026.

Q2What is Temple actually trying to measure?

Temple is worn on the side of the forehead and is being positioned as a way to monitor blood-flow and oxygenation signals associated with the brain. That moves consumer wearables closer to neurophysiology rather than simply measuring the wrist or finger.

Q3How close is this to a real product?

The team had already prepared an initial batch for selected early users, and the latest update points to paid pre-orders next. Pricing has not been officially announced in the launch post, so the key transition now is from founder-led experiments to repeatable consumer hardware.

Q4What is still unproven?

Temple has not yet published the kind of large peer-reviewed validation that would make its most ambitious health claims easy to judge. That does not make the device useless, but it means the commercial story is currently moving faster than the clinical evidence.

Q5What is the real signal?

Wearables are searching for a new sensing frontier. After years of wrist and finger data, the next battle may be over signals collected closer to the organs people actually want to understand, especially the brain.